Nishchal Chudasama

Group Leader Integrated Supply Chain Operations
Bristol Myers Squibb

Nish Chudasama is currently Group Leader Clinical Supply Chain Operations at Bristol-Myers Squibb. In this role he oversees end-to-end supply chain operations from Drug Substance and Drug Product Manufacturing to Packaging & Labeling for Clinical Supplies.

Nish has over 15 years of experience in the pharmaceutical industry, spanning various dimensions of the supply chain including Temperature Controlled Logistics, Operations Management and Customer Service. Over the course of his career Nish has supported the supply chains of several large organizations including Bristol-Myers Squibb, Novo Nordisk, Sanofi Aventis, Samsung and P&G.

Nish holds an MBA in Supply Chain from Syracuse University and an Executive Certificate in Technology, Operations & Value Chain Management from MIT.

Check out the incredible speaker line-up to see who will be joining Nishchal.

Download The Latest Agenda

Main Conference Day One

Friday, March 9th, 2018

14:20 Developing A Robust Temperature Controlled Logistics Transportation Strategy

16:45 Beer Bucket Roundtable Discussion Groups

1. Integrating IT Infrastructure: Ensuring the Successful Management of Data
Juan Fernando Forero, Sr. Director Supply Chain Leader Global Innovation Pharma (GIP), Pfizer
2. Bringing S&OP to R&D/Clinical Stage Supply Chain Planning
Mark Landau, Director Supply Chain Planning, GlaxoSmithKline - R&D Business Unit
3. Best Practices to Improve Forecasting Accuracy
Jain Aditya, Professor, Zicklin School of Business, Baruch College
4. Developing A Robust Temperature Controlled Logistics Transportation Strategy
Nischal Chudasama, Group Leader Integrated Supply Chain Operations, BMS
5. Inventory Management as a Risk Mitigation Tool
Stephen Meyer, Research Director, Gartner
6. How can digital capabilities transform the supply chain to create a competitive advantage for your organization?
Bharath Sundararaman, Global Leader, Supply Chain Visibility & Analytics, EMD Millipore
7. S&OP